Advertisement

Radiofrequency Ablation, Microwave Ablation, and Cryoablation for Lung Tumors

  • Tracey G. Simon
  • Damian E. Dupuy
Chapter

Abstract

The current standard of care for patients with early stage pulmonary neoplasms is surgical resection. However, only approximately 15% of patients are surgical candidates, due to advanced disease stage and/or severe medical comorbidities [1, 2]. For such patients, the treatment options are limited, and the 5-year survival is poor ranging from 5% to 12% [3].

Keywords

Microwave Ablation Karnofsky Performance Status Scale Metastatic Lung Lesion Metastatic Pulmonary Neoplasm Severe Medical Comorbidities 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    D’Amico T. Local control without resection. J Thorac Cardiovasc Surg. 2003;125:787–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Ginsberg RJ, Vokes EE, Raben A. Cancer of lung: non-small cell lung cancer. In: Mitchell JB, Johnson DH, Turrisi AT, editors. Lung cancer: principles and practice of oncology. 5th ed. Philadelphia, PA: Lippincott-Raven; 1996. p. 849–57.Google Scholar
  3. 3.
    Ihde DC, Minna JD. Non-small cell lung cancer. II. Treatment. Curr Probl Cancer. 1991;15:105–54.PubMedGoogle Scholar
  4. 4.
    Simon C, Dupuy DE. Current role of image-guided ablative therapies in lung cancer. Expert Rev Anticancer Ther. 2005;5(4):657–66.PubMedCrossRefGoogle Scholar
  5. 5.
    Bojarski J, Dupuy D, Mayo-Smith W. CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors. AJR Am J Roentgenol. 2005;185:466–71.PubMedGoogle Scholar
  6. 6.
    Grieco CA, Simon CJ, Mayo-Smith WW, DiPetrillo TA, Ready NE, Dupuy DE. Image-guided percutaneous thermal ablation for the palliative treatment of chest wall masses. Am J Clin Oncol. 2007;30:361–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Steinke K, Sewell PE, Dupuy D, et al. Pulmonary radiofrequency ablation – an international study survey. Anticancer Res. 2004;24:339–43.PubMedGoogle Scholar
  8. 8.
    Dupuy DE, DiPetrillo T, Gandhi S, et al. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage 1 non-small cell lung cancer. Chest. 2006;3:738–40.CrossRefGoogle Scholar
  9. 9.
    Lencioni R, Crocetti L, Cioni R. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol. 2008;9(7):621–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Akeboshi M, Yamakado K, Nakasuka A, et al. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol. 2004;15:463–70.PubMedGoogle Scholar
  11. 11.
    Yasui K, Kanazawa A, Sano Y, et al. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology. 2004;231:850–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology. 2007;243:268–75.PubMedCrossRefGoogle Scholar
  13. 13.
    Lee JM, Jin GY, Goldberg SN, et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology. 2004;230(1):125–34.PubMedCrossRefGoogle Scholar
  14. 14.
    Callstrom MR, Charboneau JW, Goetz MP, et al. Painful metastases involving bone: feasibility of percutaneous CT and US-guided radiofrequency ablation. Radiology. 2002;224(1):87–97.PubMedCrossRefGoogle Scholar
  15. 15.
    Ahmed M, Liu Z, Afzal KS, et al. Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model. Radiology. 2004;230:761–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Gananadha S, Morris DL. Saline infusion markedly reduces impedance and improves efficacy of pulmonary radiofrequency ablation. Cardiovasc Intervent Radiol. 2004;27:361–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Jain SK, Dupuy DE, Cardarelli GA, et al. Percutaneous radiofrequency ablation of pulmonary malignancies: combined treatment with brachytherapy. AJR Am J Roentgenol. 2003;181(3):711–5.PubMedGoogle Scholar
  18. 18.
    Abbas G, Schuchert MJ, Pennathur A, et al. Ablative treatments for lung tumors: radiofrequency ablation, stereotactic radiosurgery, and microwave ablation. Thorac Surg Clin. 2007;17(2):261–71.PubMedCrossRefGoogle Scholar
  19. 19.
    Herrera LJ, Fernando HC, Perry Y, et al. Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovasc Surg. 2003;125(4):929–37.PubMedCrossRefGoogle Scholar
  20. 20.
    Pennathur A, Luketich JD, Abbas G, et al. Radiofrequency ablation for the Treatment of Stage I non-small cell lung cancer in high-risk patients. J Thorac Cardiovasc Surg. 2007;134(4):857–64.PubMedCrossRefGoogle Scholar
  21. 21.
    Nomura M, Yamakado K, Nomoto Y. Complications after lung radiofrequency ablation: risk factors for lung inflammation. Br J Radiol. 2008;81:244–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Ambrogi MC, Lucchi M, Dini P, et al. Percutaneous radiofrequency ablation of lung tumors: results in the midterm. Eur J Cardiothorac Surg. 2006;30:177–83.PubMedCrossRefGoogle Scholar
  23. 23.
    Giraud P, Antoine M, Larrouy A, et al. Evaluation of microscopic tumor extension in non-small cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys. 2000;48:1015–24.PubMedCrossRefGoogle Scholar
  24. 24.
    McGovern FJ, Wood BJ, Goldberg SN, Mueller PR. Radiofrequency ablation of renal cell carcinoma via image-guided needle electrodes. J Urol. 1999;161:599–600.PubMedCrossRefGoogle Scholar
  25. 25.
    Wolf FJ, Grand DJ, Machan JT, et al. Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology. 2008;247(3):871–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Carrafiello G, Lagana D, Mangini M, et al. Microwave tumor ablation: principles, clinical applications and review of preliminary experiences. Int J Surg. 2008;6 Suppl 1:S65–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics. 2005;25:S69–83.PubMedCrossRefGoogle Scholar
  28. 28.
    Brace CL, Hinshaw JL, Laeseke PF, et al. Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model. Radiology. 2009;251(3):701–11.CrossRefGoogle Scholar
  29. 29.
    Deygas N, Froudarakis M, Ozenne G, et al. Cryotherapy in early superficial bronchogenic carcinoma. Chest. 2001;120:26–31.PubMedCrossRefGoogle Scholar
  30. 30.
    Wang H, Littrup P, Duan Y, et al. Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology. 2005;235:289–98.PubMedCrossRefGoogle Scholar
  31. 31.
    Kawamura M, Izumi Y, Tsukada N, et al. Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates. J Thorac Cardiovasc Surg. 2006;131:1007–13.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of Diagnostic ImagingWarren Alpert Medical School of Brown University, Rhode Island HospitalProvidenceUSA

Personalised recommendations